Clinical Trials: Design, Conduct, and AnalysisOxford University Press, 1986 - 469 pages The definitive reference work on clinical trials, this book presents a wealth of detailed, practical information on the design, conduct, and analysis of both single center and multicenter trials. No other book on clinical trials offers as much detail as Meinert does on such issues as sample size calculation, stratification and randomization, data systems design, consent form development, publication policies, preparation of funding requests, and reporting procedures. |
From inside the book
Results 1-5 of 69
Page xvi
... functions and responsibilities technique 20.6 The pros and cons of stopping 22.1 Management requirements rules in monitoring trials 22.2 Management deficiencies 20.7 Steps in terminating a treatment 22.2.1 Failure to delegate authority ...
... functions and responsibilities technique 20.6 The pros and cons of stopping 22.1 Management requirements rules in monitoring trials 22.2 Management deficiencies 20.7 Steps in terminating a treatment 22.2.1 Failure to delegate authority ...
Page xvii
... function PART VI . REPORTING 22.4 Advisory - review functions PROCEDURES 22.5 Committee procedures 22.6 Preferred separation of Chapter 24. Study publication and responsibilities and functions information policies 22.6.1 Separation of ...
... function PART VI . REPORTING 22.4 Advisory - review functions PROCEDURES 22.5 Committee procedures 22.6 Preferred separation of Chapter 24. Study publication and responsibilities and functions information policies 22.6.1 Separation of ...
Page xxv
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Page 8
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Page 18
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Contents
A stateof | 1 |
223 | 12 |
The activities of | 18 |
Cost and related issues | 40 |
masked allocation | 90 |
Use of items from other | 119 |
Patient recruitment | 149 |
Patient followup | 185 |
randomization | 219 |
Essential management | 232 |
Preparation of | 264 |
Appendix H Budget summary | 279 |
Other editions - View all
Common terms and phrases
Abstract summaries advisory-review allocation ratio Aspirin assess baseline Chapter clinical trial close-out consent control treatment Coronary Drug Project cost data center data collection data coordinating center data dredging data entry data forms database disease Drug Project Research Fisher's exact test follow-up visit funding Gallstone Group Diabetes Program Hypertension Institute investigators laboratory masked ment methods monitoring committee multicenter trials myocardial infarction NCGS needed niacin number of patients outcome measure p-value paper patient recruitment patients enrolled phenformin physician placebo procedures Program Research Group Project Research Group protocol publication Question randomization records responsible safety monitoring sample sample size schedule Section specified sponsor study treatments subgroups TEMC test treatment tients tion tolbutamide treat treatment allocation treatment assignment treatment effects monitoring treatment group treatment monitoring trial involving trials sketched UGDP University Group Diabetes variable Yes Yes Yes